entity

SLC13A3

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about SLC13A3: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

18Connections

0Hypotheses

0Analyses

11Outgoing

7Incoming

Wiki Pages (2)

Knowledge base pages for this entity

SLC13A2 — Solute Carrier Family 13 Member 2 (Na+-dependent citrate transporter)

gene · 951 words

→

SLC13A1 — Solute Carrier Family 13 Member 1 (Na+-dependent sulfate transporter)

gene · 580 words

→

Outgoing (11)

Target	Relation	Type	Str
ferroptosis resistance	promotes	phenotype	0.95
liver cancer	therapeutic_target	disease	0.93
ferroptosis	promotes	process	0.92
NRF2	activates	protein	0.90
MTOR	upstream_of	gene	0.88
immune checkpoint blockade	inhibits	process	0.85
MYC	regulates	gene	0.85
ferroptosis	participates_in	pathway	0.60
SLC7A5	inhibits	gene	0.60
autophagy pathway	participates_in	pathway	0.60
benchmark_ot_ad_answer_key:SLC13A3	data_in	dataset_row	0.00

Incoming (7)

Source	Relation	Type	Str
CTNNB1	upstream_of	gene	0.95
CTNNB1	expressed_in	gene	0.60
MYC	inhibits	gene	0.60
CTNNB1	targets	gene	0.60
GSH	translocates_to	gene	0.60
GSH	activates	gene	0.60
benchmark_ot_ad_answer_key:SLC13A3	data_in	dataset_row	0.00

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
No targeting hypotheses

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found